Offering Details. In connection with the Offering, the Issuer is offering Securities for sale as follows: Securities Offered: Common Stock Minimum Funding Amount: $6,000,0001 Maximum Funding Amount: $15,000,0002
Appears in 1 contract
Sources: Offering Deposit Account Agency Agreement (CNS Pharmaceuticals, Inc.)
Offering Details. In connection with the Offering, the Issuer is offering Securities for sale as follows: Securities Offered: Common Stock Minimum Funding Amount: $6,000,0001 6,000,0001: Maximum Funding Amount: $15,000,000215,000,000 2
Appears in 1 contract
Sources: Offering Deposit Account Agency Agreement (CNS Pharmaceuticals, Inc.)
Offering Details. In connection with the Offering, the Issuer is offering Securities securities for sale as follows: Securities Offered: Common Stock Minimum Funding AmountAmount1: $6,000,0001 500,000 Maximum Funding AmountOffered: $15,000,00025,000,000 Termination Date2: One year from this offering being qualified by the Commission.
Appears in 1 contract
Sources: Offering Deposit Account Agency Agreement (Electromedical Technologies, Inc)